|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
1996-11-1
|
|
pubmed:abstractText |
Radical changes are currently taking place in the treatment of duodenal ulcer, where strategies of eradication of Helicobacter pylori are replacing traditional antisecretory treatment. The aim of this study is to present the economic aspects of the different therapeutic approaches.
|
|
pubmed:language |
fre
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0399-8320
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1023-30
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8729415-Anti-Ulcer Agents,
pubmed-meshheading:8729415-Combined Modality Therapy,
pubmed-meshheading:8729415-Cost-Benefit Analysis,
pubmed-meshheading:8729415-Duodenal Ulcer,
pubmed-meshheading:8729415-Helicobacter Infections,
pubmed-meshheading:8729415-Helicobacter pylori,
pubmed-meshheading:8729415-Histamine H2 Antagonists,
pubmed-meshheading:8729415-Humans,
pubmed-meshheading:8729415-Omeprazole,
pubmed-meshheading:8729415-Proton Pumps,
pubmed-meshheading:8729415-Randomized Controlled Trials as Topic,
pubmed-meshheading:8729415-Ranitidine
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
[Medico-economic aspects of the treatment of duodenal ulcer: from antisecretory treatment to eradication of Helicobacter pylori].
|
|
pubmed:affiliation |
CNRS URA 934, Université Lyon 1, Villeurbanne.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
English Abstract
|
